PERBANDINGAN GEJALA KEJADIAN IKUTAN PASCA IMUNISASI SETELAH VAKSIN COVID-19 ASTRAZENECA PERTAMA DAN KEDUA DI CENTRAL VAKSINASI UTA 45 JAKARTA

Authors

  • Stefanus Lukas Fakultas Farmasi, Universitas Andalas
  • Diana Laila Ramatillah Fakultas Farmasi, Universitas Andalas
  • Yufri Aldi Fakultas Farmasi, Universitas Andalas
  • Fatma Sri Wahyuni Fakultas Farmasi, Universitas Andalas

DOI:

https://doi.org/10.36387/jiis.v9i1.1879

Keywords:

AEFI 1 & 2, Astrazeneca, Covid 19, Symptoms

Abstract

Post-Immunization Adverse Events (AEFI) are common among vaccine participants. AEFI needs to be evaluated because Covid-19 vaccination is an effort to prevent Covid-19 infection which is still relatively new and people are still afraid of post-immunization adverse events occurring. In order for community participation to increase, it is deemed necessary to carry out an AEFI evaluation for both the first dose and the second dose (complete dose). This study aims to evaluate the symptoms of AEFI 1 with AEFI 2 by measuring the number of respondents who caused local and systemic reactions after COVID-19 vaccination. The retrospektive and prospective cross sectional study were used in this study with about 113 Astrazeneca vaccine participants at the UTA'45 Jakarta vaccine center and the data met the inclusion and exclusion criteria. Data was collected through questionnaires, AEFI forms and interviews based on symptoms of local and systemic reactions. Of the 113 participants, 29 were female, while 84 were male and the reactions they caused were different, such as pain, redness, swelling at the injection site, such as fever, muscle aches throughout the body, joint pain and also weakness. Comparison of symptoms of local and systemic reaction between KIPI 1and KIPI 2. In those without symptoms, there was increase number, but in those with symptoms, the number of respondens decrease, and statistically there was sig, P value <0,05.

References

Abbas, A. ., Lichtman, A. . and Pober, J. S. (2000) Cellular and Molecular Immunologi. 4th edn. Philadephia: W.B Saunder Company.

Ahmed, R., Lanier, J. G. and Pamer, E. (2002) ‘Immunological Memory and Infection, dalam Kaufman, E ., Sher, A. and Ahmed, R.’, Imunologi Of Infection Disease, Asm Press, Washington D.C.

Desnita, R., Sapardi, V. S. and Surya, D. O. (2022) ‘Kejadian Ikutan Pasca Imunisasi (KIPI) Vaksin Covid-19 Dosis Pertama dan Kedua’, Jik Jurnal Ilmu Kesehatan, 6(1), p. 20. doi: 10.33757/jik.v6i1.480.

Dhamanti, I. et al. (2023) ‘Adverse Reactions of COVID-19 Vaccines: A Scoping Review of Observational Studies’, International Journal of General Medicine, 16(February), pp. 609–618. doi: 10.2147/IJGM.S400458.

Ermayanti, S. et al. (2023) ‘Correlation of the Adverse Event Following Immunization with the Severity of COVID-19 Infection in Health Care Workers in Padang’, Bioscientia Medicina : Journal of Biomedicine and Translational Research, 7(7), pp. 3406–3412. doi: 10.37275/bsm.v7i7.837.

Gurtman, A. et al. (2020) ‘new england journal’, pp. 2603–2615. doi: 10.1056/NEJMoa2034577.

Hofmeyr, S. A. (2000) ‘An interpretative introduction to the immune system’, Dept. of Computer Science University of New Mexico, 3, pp. 3–26. Available at: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:An+Interpretative+Introduction+to+the+Immune+System#0.

Kemenkes RI (2021) ‘Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/4638/2021 Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (Covid-19)’, Jurnalrespirologi.Org, 2019(2), pp. 1–4.

Kemenkes RI, 2021 (2021) ‘Keputusan Direktur Jenderal Pencegahan dan Pengendalian Penyakit Nomor Hk.02.02/4/1/2021 tentang Petunjuk Teknis Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19)’, Kementerian Kesehatan RI, 4247608(021), p. 114.

Kewan, T. et al. (2021) ‘Characteristics and outcomes of adverse events after COVID-19 vaccination’, JACEP Open, 2(5), pp. 1–10. doi: 10.1002/emp2.12565.

Kresno, B. S. (2010) ‘Imunologi: Diagnosis dan Prosedur Laboratorium, EdisiV, hal 26, 30, 36, Badan Penerbit Fakultas Kedokteran Universitas Indonesia, Jakarta.’, p. 2010.

Mona, N. (2020) ‘Konsep isolasi dalam jaringan sosial untuk meminimalisasi efek contagious (Kasus penyebaran virus corona di Indonesia)’, Jurnal Sosial Humaniora Terapan, 2(2), pp. 117–125.

Murphy, K. (2012) Janeway’s Immunobiology. Eight Edit. London: Garland Science.

Oyebanji, O. A. et al. (2021) ‘Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?’, Aging Clinical and Experimental Research, 33(11), pp. 3151–3160. doi: 10.1007/s40520-021-01987-9.

Ramatillah, D. L. et al. (2021) ‘Public Knowledge about COVID-19 and Its Impact on the Psychic Condition of Indonesian Society’, 48(8).

Roitt, I. M. et al. (2017) Adversarial Strategies During Infection. 13th edn. Kingdom United: Wiley Blackwell.

Silkane, V. and Austers, I. (2017) ‘Exploring 35-44 Year Old Men’S Health Behaviour: a Qualitative Perspective’, SOCIETY. INTEGRATION. EDUCATION. Proceedings of the International Scientific Conference, 1(January), p. 649. doi: 10.17770/sie2017vol1.2289.

Utami, W. et al. (2022) ‘Adverse Events Following Immunization (AEFI) of COVID-19 vaccines and their association with comorbidities in health personnel and public servants in Indonesia’, Public Health of Indonesia, 8(2), pp. 39–45. doi: 10.36685/phi.v8i2.587.

WHO (2021) ‘Interim recommendations for use of the ChAdOx1-S [ recombinant ] vaccine against COVID-19’, World Health Organization, 19(January), pp. 1–12. Available at: WHO/2019-nCoV/vaccines/SAGE_recommendation/BNT162b2/2021.1.

World Health Organization (2021) ‘Rekomendasi interim untuk penggunaan vaksin COVID-19 inaktivasi, CoronaVac, yang dikembangkan oleh Sinovac’, Panduan Interim, 1(4), pp. 1–7. Available at: https://www.who.int/indonesia/news/novel-coronavirus.

Published

2024-03-31

Issue

Section

Article

How to Cite

PERBANDINGAN GEJALA KEJADIAN IKUTAN PASCA IMUNISASI SETELAH VAKSIN COVID-19 ASTRAZENECA PERTAMA DAN KEDUA DI CENTRAL VAKSINASI UTA 45 JAKARTA . (2024). Jurnal Ilmiah Ibnu Sina, 9(1), 228-236. https://doi.org/10.36387/jiis.v9i1.1879

Similar Articles

1-10 of 54

You may also start an advanced similarity search for this article.